These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 16896282)

  • 1. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells.
    Grimaldi CM
    Curr Opin Rheumatol; 2006 Sep; 18(5):456-61. PubMed ID: 16896282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal modulation of B cell development and repertoire selection.
    Grimaldi CM; Hill L; Xu X; Peeva E; Diamond B
    Mol Immunol; 2005 May; 42(7):811-20. PubMed ID: 15829269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes.
    Peeva E; Zouali M
    Immunol Lett; 2005 Nov; 101(2):123-43. PubMed ID: 16061292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin as a modulator of B cell function: implications for SLE.
    Peeva E; Venkatesh J; Michael D; Diamond B
    Biomed Pharmacother; 2004 Jun; 58(5):310-9. PubMed ID: 15194167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice.
    Zhang Y; Saha S; Rosenfeld G; Gonzalez J; Pepeljugoski KP; Peeva E
    J Rheumatol; 2010 Aug; 37(8):1646-57. PubMed ID: 20551107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoreactive anti-DNA transgenic B cells in lupus-prone New Zealand black/New Zealand white mice show near perfect L chain allelic exclusion.
    Makdasi E; Fischel R; Kat I; Eilat D
    J Immunol; 2009 May; 182(10):6143-8. PubMed ID: 19414767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
    Fournel S; Muller S
    Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal regulation of B-cell function and systemic lupus erythematosus.
    Cohen-Solal JF; Jeganathan V; Hill L; Kawabata D; Rodriguez-Pinto D; Grimaldi C; Diamond B
    Lupus; 2008 Jun; 17(6):528-32. PubMed ID: 18539705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide.
    Ferrera F; Hahn BH; Rizzi M; Anderson M; Fitzgerald J; Millo E; Indiveri F; Shi FD; Filaci G; La Cava A
    Arthritis Rheum; 2007 Jun; 56(6):1945-53. PubMed ID: 17530718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal milieu at time of B cell activation controls duration of autoantibody response.
    Jeganathan V; Peeva E; Diamond B
    J Autoimmun; 2014 Sep; 53():46-54. PubMed ID: 24685232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.
    Enzler T; Bonizzi G; Silverman GJ; Otero DC; Widhopf GF; Anzelon-Mills A; Rickert RC; Karin M
    Immunity; 2006 Sep; 25(3):403-15. PubMed ID: 16973390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell receptor signaling in human systemic lupus erythematosus.
    Pugh-Bernard AE; Cambier JC
    Curr Opin Rheumatol; 2006 Sep; 18(5):451-5. PubMed ID: 16896281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subset size, activation threshold and distribution of autoreactive MZ and FO B cells do not differ in a sex-specific manner in the NZB/W F1 murine lupus model: an experimental mouse study.
    Enghard P; Grussie E; Rieder C; Burmester GR; Riemekasten G
    Lupus; 2011 Oct; 20(12):1240-9. PubMed ID: 21844114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen and CD4+ T cells.
    Pernis AB
    Curr Opin Rheumatol; 2007 Sep; 19(5):414-20. PubMed ID: 17762604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous B cell hyperactivity in autoimmune-prone MRL mice.
    Nijnik A; Ferry H; Lewis G; Rapsomaniki E; Leung JC; Daser A; Lambe T; Goodnow CC; Cornall RJ
    Int Immunol; 2006 Jul; 18(7):1127-37. PubMed ID: 16735376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide-based immunotherapy of systemic lupus erythematosus.
    Monneaux F; Muller S
    Autoimmun Rev; 2004 Jan; 3(1):16-24. PubMed ID: 14871645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender disparity in systemic lupus erythematosus, thoughts after the 8th International Congress on Systemic Lupus Erythematosus, Shanghai, China, 2007.
    Lahita RG
    J Clin Rheumatol; 2008 Jun; 14(3):185-7. PubMed ID: 18525443
    [No Abstract]   [Full Text] [Related]  

  • 18. Restoration of tolerance in lupus by targeted inhibitory receptor expression.
    McGaha TL; Sorrentino B; Ravetch JV
    Science; 2005 Jan; 307(5709):590-3. PubMed ID: 15681388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus: all roads lead to type I interferons.
    Pascual V; Farkas L; Banchereau J
    Curr Opin Immunol; 2006 Dec; 18(6):676-82. PubMed ID: 17011763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production.
    Takeno M; Nagafuchi H; Kaneko S; Wakisaka S; Oneda K; Takeba Y; Yamashita N; Suzuki N; Kaneoka H; Sakane T
    J Immunol; 1997 Apr; 158(7):3529-38. PubMed ID: 9120315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.